ArticleCureus2026
Lithium Toxicity or Alcohol Withdrawal?
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lithium has a narrow therapeutic index and remains the first-line treatment for bipolar I and II disorders. Dosing this medication requires careful monitoring, and there is a risk of toxicity. This case follows a 43-year-old male with a medical history of alcohol use and bipolar I disorder, admitted to the hospital three days after an intentional lithium overdose. Initial management involved treating alcohol withdrawal with scheduled phenobarbital, lorazepam, and intravenous fluids. In the following days, he demonstrated a neurologic decline in the setting of subtherapeutic serum lithium levels. As the patient continued to worsen, hemodialysis was eventually initiated due to concern for lithium neurotoxicity. After completing three rounds of hemodialysis, the patient subsequently returned to a normal neurologic baseline. This case highlights the significance of clinical manifestations of lithium toxicity in the setting of subtherapeutic and down-trending serum lithium to manage lithium toxicity. Pre-existing tissue stores and rate of elimination contribute to the discrepancy between the severity of symptoms and serum levels in those with chronic lithium use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.